Effects of CYP3A4*22 and POR*28 variations on the pharmacokinetics of tacrolimus in renal transplant recipients: a meta-analysis of 18 observational studies

被引：0
|
作者：
Ze Li
Xiaozhen Wang
Dandan Li
Sheng Cheng
Zhe Li
Heng Guo
Yiwen Dong
Yingming Zheng
Xingang Li
机构：
[1] Beijing Friendship Hospital,Department of Pharmacy
[2] Capital Medical University,Central Laboratory
[3] Xuanwu Hospital,undefined
[4] Capital Medical University,undefined
来源：
BMC Nephrology | / 25卷
关键词：
Meta-analysis; Genetic polymorphisms; Tacrolimus; Pharmacokinetics; Renal transplant recipients;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Effects of CYP3A5 Genetic Polymorphism on the Pharmacokinetics of Tacrolimus in Renal Transplant Recipients
    Mac Guad, R.
    Zaharan, N. L.
    Chik, Z.
    Mohamed, Z.
    Peng, N. K.
    Adnan, W. A. H. W. M.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (01) : 81 - 87
  • [22] The impact of CYP3A5*3 and CYP3A4*22 polymorphisms on Tacrolimus pharmacokinetics in a caucasian kidney transplant cohort
    Abdel-Kahaar, E.
    Winter, S.
    Schaeffeler, E.
    Olbricht, C.
    Shipkova, M.
    Schwab, M.
    Wieland, E.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2018, 391 : S74 - S74
  • [23] Influence of CYP3A4, CYP3A5 and MDR-1 polymorphisms on tacrolimus pharmacokinetics and early renal dysfunction in liver transplant recipients
    Shi, Yunying
    Li, Yi
    Tang, Jiangtao
    Zhang, Junlong
    Zou, Yuangao
    Cai, Bei
    Wang, Lanlan
    GENE, 2013, 512 (02) : 226 - 231
  • [24] Effect of Age and Allele Variants of CYP3A5, CYP3A4, and POR Genes on the Pharmacokinetics of Cyclosporin A in Pediatric Renal Transplant Recipients From Serbia
    Cvetkovic, Mirjana
    Zivkovic, Maja
    Bundalo, Maja
    Gojkovic, Ivana
    Spasojevic-Dimitrijeva, Brankica
    Stankovic, Aleksandra
    Kostic, Mirjana
    THERAPEUTIC DRUG MONITORING, 2017, 39 (06) : 589 - 595
  • [25] IMPACT OF CYP3A4*22, CYP3A5*1 AND POR*28 POLYMORPHISMS ON TACROLIMUS DOSE OPTIMIZATION AND THE OUTCOME OF KIDNEY TRANSPLANTATION
    Elens, Laure
    Padulles, Ariadna
    Llaudo, Ines
    Van Gelder, Teun
    Hesselink, Dennis A.
    Torras, Joan
    Cruzado, Josep M.
    Bestard, Oriol
    Colom, Helena
    Andreu, Franc
    Grinyo, Josep M.
    Van Shaik, Ron
    Lloberas, Nuria
    TRANSPLANT INTERNATIONAL, 2015, 28 : 497 - 497
  • [26] EFFECT OF CYP3A5, CYP3A4, POR AND ABCB1 POLYMORPHISMS ON TACROLIMUS METABOLISM IN RENAL TRANSPLANT PATIENTS
    Chong, Winnie
    Hamilton-Jones, Siobhan
    Kim, Jon Jin
    Navarrete, Cristina V.
    Key, Tim
    Howell, Martin W.
    HLA, 2020, 95 (04) : 316 - 316
  • [27] The CYP3A4*22 Allelic Variant Increases the Risk of Tacrolimus Overexposure in Kidney Transplant Recipients.
    Nicolas, P.
    Manele, E.
    Isebelle, E.
    Mathias, B.
    Gabriel, C.
    Guy, T.
    Cecile, V.
    Bruno, M.
    Yann, L.
    Eric, T.
    TRANSPLANTATION, 2014, 98 : 676 - 676
  • [28] CYP3A4*22 and CYP3A combined genotypes both correlate with tacrolimus disposition in pediatric heart transplant recipients
    Gijsen, Violette M. G. J.
    van Schaik, Ron H. N.
    Elens, Laure
    Soldin, Offie P.
    Soldin, Steven J.
    Koren, Gideon
    de Wildt, Saskia N.
    PHARMACOGENOMICS, 2013, 14 (09) : 1027 - 1036
  • [29] The Impact of CYP3A4*22 on Tacrolimus Pharmacokinetics and Outcome in Clinical Practice at a Single Kidney Transplant Center
    Abdel-Kahaar, Emaad
    Winter, Stefan
    Tremmel, Roman
    Schaeffeler, Elke
    Olbricht, Christoph J.
    Wieland, Eberhard
    Schwab, Matthias
    Shipkova, Maria
    Jaeger, Simon U.
    FRONTIERS IN GENETICS, 2019, 10
  • [30] The CYP3A4*22 Allelic Variant Increases the Risk of Tacrolimus Overexposure in Kidney Transplant Recipients.
    Nicolas, P.
    Manele, E.
    Isebelle, E.
    Mathias, B.
    Gabriel, C.
    Guy, T.
    Cecile, V.
    Bruno, M.
    Yann, L.
    Eric, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 676 - 676
12345